Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Anorexia × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 70 Neoplasms, Plasma Cell 23 Neoplasms 12 Brain Neoplasms 11 Central Nervous System Neoplasms 10 Prostatic Neoplasms 9 Melanoma 8 Leukemia 8 Glioblastoma 8 Gliosarcoma 7 Glioma 7 Leukemia, Lymphocytic, Chronic, B-Cell 5 Waldenstrom Macroglobulinemia 4 Sarcoma 4 Recurrence 4 Myeloproliferative Disorders 4 Myelodysplastic Syndromes 4 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell, Marginal Zone 4 Lung Neoplasms 4 Immunoglobulin Light-chain Amyloidosis 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Oligodendroglioma 3 Neuroblastoma 3 Myelodysplastic-Myeloproliferative Diseases 3 Lymphoma 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Carcinoma, Ovarian Epithelial 3 Astrocytoma 3

Interventions

Megestrol Acetate 4 Mirtazapine 2 Infliximab 2 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Palonosetron 1 Olanzapine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Gemcitabine 1 Etanercept 1 Eicosapentaenoic Acid 1 Docetaxel 1 Creatine 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡